The press releases and information stored here shall not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company. To the extent that statements in the press releases and information stored here are not strictly historical, including statements as to the Company's business strategy, outlook, objectives, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's product development, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in these releases are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Among the factors which could affect the Company's actual results and could cause  results to differ from those contained in the forward-looking statements contained herein are the risk that financial conditions may change, the risk that the Company will not be able to raise additional capital or enter into additional collaboration agreements, risks relating to the progress of the Company's research and development and the development of competing therapies and/or technologies by other companies.  Those associated risks and others are further described in the Company's periodic filings with the Securities and Exchange Commission, including the most recent reports on Forms 10-KSB, 8-K, 10-QSB and 10-Q, and amendments thereto.